PAWC
P.A.W. Capital Portfolio holdings
AUM
$51.9M
This Quarter Return
+10.91%
1 Year Return
+46.14%
3 Year Return
+74.13%
5 Year Return
+167.35%
10 Year Return
+839.74%
AUM
$91.4M
AUM Growth
+$91.4M
(+9.9%)
Cap. Flow
+$230K
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
41.47%
Holding
71
New
8
Increased
19
Reduced
22
Closed
7
Top Buys
| 1 |
Semler Scientific
SMLR
|
$1.39M |
| 2 |
EFII
Electronics for Imaging
EFII
|
$1.3M |
| 3 |
Akebia Therapeutics
AKBA
|
$998K |
| 4 |
Gaia
GAIA
|
$810K |
| 5 |
Digital Turbine
APPS
|
$755K |
Top Sells
| 1 |
WEB
Web.com Group, Inc.
WEB
|
$2.17M |
| 2 |
WIFI
Boingo Wireless, Inc.
WIFI
|
$991K |
| 3 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$868K |
| 4 |
Chegg
CHGG
|
$834K |
| 5 |
Varonis Systems
VRNS
|
$745K |
Sector Composition
| 1 | Technology | 32.86% |
| 2 | Healthcare | 15.33% |
| 3 | Communication Services | 15.16% |
| 4 | Consumer Staples | 11.18% |
| 5 | Industrials | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Galmed Pharmaceuticals
GLMD
$6.96M
| $1.13M | 1.14% | 95,000 -5,000 | -5% | -$59.5K |
|
|
CCXI
27
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.12M | 1.13% | 85,000 +10,000 | +13% | +$132K |
|
|
EIGR
28
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.1M | 1.11% | 90,000 -45,000 | -33% | -$549K |
|
29
LendingTree
TREE
$925M
| $1.07M | 1.08% | 5,000 | – | – |
|
|
30
Akebia Therapeutics
AKBA
$833M
| $998K | 1.01% | +100,000 | New | +$998K |
|
|
RDS.A
31
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $831K | 0.84% | 12,000 -500 | -4% | -$34.6K |
|
32
Galapagos
GLPG
$2.07B
| $830K | 0.84% | 9,000 | – | – |
|
33
Verizon
VZ
$186B
| $755K | 0.76% | 15,000 -1,500 | -9% | -$75.5K |
|
34
Kraft Heinz
KHC
$33.1B
| $691K | 0.7% | +11,000 | New | +$691K |
|
35
Altria Group
MO
$113B
| $681K | 0.69% | 12,000 +2,000 | +20% | +$114K |
|
36
Merck
MRK
$210B
| $668K | 0.67% | 11,000 -1,000 | -8% | -$60.7K |
|
37
Johnson & Johnson
JNJ
$427B
| $667K | 0.67% | 5,500 +500 | +10% | +$60.6K |
|
38
DuPont de Nemours
DD
$32.2B
| $659K | 0.67% | 10,000 | – | – |
|
39
Coca-Cola
KO
$297B
| $658K | 0.66% | 15,000 | – | – |
|
40
PepsiCo
PEP
$204B
| $653K | 0.66% | 6,000 | – | – |
|
41
Pfizer
PFE
$141B
| $653K | 0.66% | 18,000 -2,000 | -10% | -$72.6K |
|
42
Philip Morris
PM
$260B
| $646K | 0.65% | 8,000 +1,000 | +14% | +$80.8K |
|
43
GSK
GSK
$79.9B
| $645K | 0.65% | 16,000 | – | – |
|
44
BP
BP
$90.8B
| $639K | 0.65% | 14,000 -2,000 | -13% | -$91.3K |
|
45
Chevron
CVX
$324B
| $632K | 0.64% | 5,000 -500 | -9% | -$63.2K |
|
46
Procter & Gamble
PG
$368B
| $624K | 0.63% | 8,000 +500 | +7% | +$39K |
|
47
Omega Healthcare
OHI
$12.6B
| $620K | 0.63% | 20,000 -5,000 | -20% | -$155K |
|
48
Exxon Mobil
XOM
$487B
| $620K | 0.63% | +7,500 | New | +$620K |
|
49
Abbott
ABT
$231B
| $610K | 0.62% | 10,000 -2,000 | -17% | -$122K |
|
50
TotalEnergies
TTE
$137B
| $606K | 0.61% | 10,000 -2,000 | -17% | -$121K |
|